Journal of Movement Disorders

Papers
(The TQCC of Journal of Movement Disorders is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Efficacy and Safety of Zolpidem for Musician’s Dystonia37
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene37
Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy29
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Masquerading as Charcot-Marie-Tooth Disease: A Case Study and Literature Review of Korean Patients29
Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined29
Anti-IgLON5-Related Movement Disorders: A Series of Three Cases from a Tertiary Centre in India23
The Landscape of Parkinson’s Disease Treatment in India: A National Cross-Sectional Survey of Clinical Practitioners19
The First Indian Patient With Benign Hereditary Chorea due to a De Novo Mutation in the NKX2-1 Gene17
Pain Characteristics of Parkinson’s Disease Using Validated Arabic Versions of the King’s Parkinson’s Disease Pain Scale and Questionnaire: A Multicenter Egyptian Study16
Knowledge, Attitudes and Perceptions of Genetic Testing Among Patients With Movement Disorders, Their Caregivers and Health Care Professionals16
Congenital ataxic phenotype of ITPR1 -related disorder due to novel missense variants – A video case series15
Neuropsychiatric and cognitive safety of subcutaneous foslevodopa/foscarbidopa in advanced Parkinson’s disease: insights from a real-world cohort14
Evaluating the Validity and Reliability of the Korean Version of the Scales for Outcomes in Parkinson’s Disease–Cognition14
Investigation of the Long-Term Effects of Amantadine Use in Parkinson’s Disease14
Association Between Gait and Dysautonomia in Patients With De Novo Parkinson’s Disease: Forward Gait Versus Backward Gait13
Muscle Dystonia Manifesting as Unilateral Rectus Abdominis Hypertrophy and Abdominal Pain in Parkinson’s Disease: A Case Report13
Dystonic Opisthotonus in Kufor-Rakeb Syndrome: Expanding the Phenotypic and Genotypic Spectrum12
Comparing Montreal Cognitive Assessment Performance in Parkinson’s Disease Patients: Age- and Education-Adjusted Cutoffs vs. Machine Learning11
DHDDS Mutation: A Rare Cause of Refractory Epilepsy and Hyperkinetic Movement Disorder11
Joubert Syndrome Presenting With Levodopa-Responsive Parkinsonism11
The Application of Deep Brain Stimulation in the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity10
Validity and Reliability of the Korean-Translated Version of the International Cooperative Ataxia Rating Scale in Cerebellar Ataxia9
Syringomyelia Manifesting With Pseudodystonia: A Case Report9
Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report9
High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington’s Disease Gene Expansion Carriers8
Jaw Opening Myoclonus in Subacute Sclerosing Panencephalitis: A New Phenotypic Observation8
Adult-Onset Genetic Leukoencephalopathies With Movement Disorders8
MRI-Guided Focused Ultrasound in Parkinson’s Disease and Essential Tremor: Incisionless but Invasive. A Narrative Review7
Absence of Alpha-Synuclein Aggregation in Patients With Parkinson’s Disease Complicated by Sigmoid Volvulus7
Association Between Exposure to Particulate Matter and the Incidence of Parkinson’s Disease: A Nationwide Cohort Study in Taiwan7
Historical and More Common Nongenetic Movement Disorders From Asia7
Efficacy of Levodopa/Benserazide Dispersible Tablets on “Delayed ON ” to the First Morning Dose in Patients With Parkinson’s Disease With Motor Fluctuations: A Multicenter, Randomized, Open-Label, Cro7
Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review7
A Novel Variant of GCH1 in Dopa-Responsive Dystonia With Oculogyric Crises and Intrafamilial Phenotypic Heterogeneity7
Early-Onset Spastic Ataxia in a Patient With the Prion (PRNP) p.Val180Ile Variant7
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy6
Reliability and Validity of the Embouchure Dystonia Severity Rating Scale6
Rapid-Onset Dystonia and Parkinsonism in a Patient With Gaucher Disease6
Challenges in Parkinson’s Disease Care—In Light of the COVID-19 Pandemic6
Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism6
Cervical proprioception in Parkinson's disease and its correlation with manual dexterity function6
The First East Asian Patient With Parkinson’s Disease Caused by the A53E SNCA Mutation With Early Progression to Dementia6
Shoulder Dysfunction in Parkinson’s Disease: Implications of Motor Subtypes, Disease Severity, and Spinopelvic Alignment6
The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome6
Effect of Positional Changes on Cerebral Perfusion in Parkinson’s Disease Patients With Orthostatic Hypotension6
“Face of the Giant Panda” Sign and Bilateral Thalamic Hyperintensity in Isoniazid-Induced Ataxia6
Copper Deficiency Myeloneuropathy in a Patient With Wilson’s Disease6
Sex and Gender Influence Urinary Symptoms and Management in Multiple System Atrophy6
Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?6
Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease5
The Goal Attainment Scale Refines Patient-Centered Expectations in Botulinum Toxin Treatment of Cervical Dystonia5
Successful Treatment of a Patient With Tremors and Extensive Brain Lesions Using Posterior Subthalamic Area–Deep Brain Stimulation5
Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia5
A Novel Pathogenic PSEN1 Variant in a Patient With Dystonia-Parkinsonism Without Dementia5
Brittle Response to Levodopa as a Marker of Parkinson’s Disease Phenotype Characterized by Heavy Motor and Non Motor Burden5
Deep Brain Stimulation in Advanced Parkinson’s Disease: An Uncommon Case of Allergic Encephalitis5
Adjustability of Gait Speed in Clinics and Free-Living Environments for People With Parkinson’s Disease5
The Effects of Biofeedback Therapy on Anxiety and Depression in Parkinson’s Disease: A Pilot Study5
Clinical and Structural Characteristics of NEU1 Variants Causing Sialidosis Type 15
‘Subthreshold’ Expansions in Individuals with Otherwise Typical Clinico-Radiological Features of GAA- FGF14 -Related Cerebellar Ataxia (SCA27B)5
From Evidence to the Dish: A Viewpoint of Implementing a Thai-Style Mediterranean Diet for Parkinson’s Disease5
Extraction of the pull force from inertial sensors during the pull test for Parkinson’s disease: A reliability study5
Adult-onset Familial TUBB4A -related Leukodystrophy Caused by c.286G>A (p.Gly96Arg) in a Korean Family: A Case Report5
Acute Extrapyramidal Side Effects Following Domperidone Intake in a 48-Year-Old Female Patient: The First Genetic Alteration and Drug Interaction Characterized5
0.25417613983154